Associated Papers
TP53 mutations predict for poor outcomes in patients with newly diagnosed aggressive B-cell lymphomas in the current era.
Landsburg DJ et al.
Blood Advances, 2023
37851898 (PubMed )
Supplement: BLOODA_ADV-2023-011384-mmc1.pdf
Cell-Free DNA for Genomic Analysis in Primary Mediastinal Large B-Cell Lymphoma.
Rivas-Delgado A et al.
Diagnostics (basel, Switzerland), 2022
35885481 (PubMed )
Supplement: diagnostics-12-01575-s001.zip › Supp_Files › diagnostics-1749759_Supp_Tables_R1.xlsx › Table_S2
SOCS1 mutation subtypes predict divergent outcomes in diffuse large B-Cell lymphoma (DLBCL) patients.
Schif B et al.
Oncotarget, 2013
23296022 (PubMed )
Supplement: oncotarget-04-035-s001.pdf
Identification of a nuclear localization signal in suppressor of cytokine signaling 1.
Baetz A et al.
Faseb Journal : Official Publication of the Federation of American Societies for Experimental Biology, 2008
Select a paper to view details